Your shopping cart is currently empty

ER-851 is a selective AXL inhibitor with oral activity, exhibiting an IC50 of 100 nM. It possesses antitumor properties.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | ER-851 is a selective AXL inhibitor with oral activity, exhibiting an IC50 of 100 nM. It possesses antitumor properties. |
| In vivo | ER-851, administered at doses ranging from 1-100 mg/kg via gavage once daily, demonstrated the ability to inhibit tumor growth in xenograft mouse models implanted with HeLa and HCC1806 cells. |
| Molecular Weight | 668.76 |
| Formula | C36H41FN8O4 |
| Cas No. | 2685738-33-2 |
| Smiles | O=C(NC1=CC=C(OC2=NC=NC3=C2CCN(C3)CC4CCN(C)CC4)C(F)=C1)C5=CN(C(=O)N(C5=O)C6=NC=C(C=C6)C)C7CCCC7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.